8-53242895-T-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000912.5(OPRK1):​c.258-7784A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000176 in 1,135,474 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000018 ( 0 hom. )

Consequence

OPRK1
NM_000912.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.189

Publications

0 publications found
Variant links:
Genes affected
OPRK1 (HGNC:8154): (opioid receptor kappa 1) This gene encodes an opioid receptor, which is a member of the 7 transmembrane-spanning G protein-coupled receptor family. It functions as a receptor for endogenous ligands, as well as a receptor for various synthetic opioids. Ligand binding results in inhibition of adenylate cyclase activity and neurotransmitter release. This opioid receptor plays a role in the perception of pain and mediating the hypolocomotor, analgesic and aversive actions of synthetic opioids. Variations in this gene have also been associated with alcohol dependence and opiate addiction. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPRK1NM_000912.5 linkc.258-7784A>C intron_variant Intron 2 of 3 ENST00000265572.8 NP_000903.2 P41145-1
OPRK1NM_001282904.2 linkc.-167A>C 5_prime_UTR_variant Exon 3 of 5 NP_001269833.1 P41145-2
OPRK1NM_001318497.2 linkc.258-7784A>C intron_variant Intron 2 of 3 NP_001305426.1 P41145A0A5F9ZI09

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPRK1ENST00000265572.8 linkc.258-7784A>C intron_variant Intron 2 of 3 1 NM_000912.5 ENSP00000265572.3 P41145-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000176
AC:
2
AN:
1135474
Hom.:
0
Cov.:
31
AF XY:
0.00000180
AC XY:
1
AN XY:
556810
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24364
American (AMR)
AF:
0.00
AC:
0
AN:
28228
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15902
East Asian (EAS)
AF:
0.00
AC:
0
AN:
12752
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76024
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4396
European-Non Finnish (NFE)
AF:
0.00000217
AC:
2
AN:
919760
Other (OTH)
AF:
0.00
AC:
0
AN:
41460
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.0
DANN
Benign
0.65
PhyloP100
-0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12548098; hg19: chr8-54155455; API